Serialization 2.0 — Moving Beyond Compliance

Serialization is a great achievement for our industry. However, most executives now realize that it is only part of the solution, and serialization alone cannot solve the escalating problems of counterfeiting and diversion within the pharmaceutical industry. The global value of pharmaceutical counterfeiting is $200B annually. More staggering is that the gray market is forecasted to reach almost $3 trillion by 2022.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

The digital lab of the 21st century

Life science companies face major obstacles to continue operations and profitability. Examples include patent expirations, low research and development productivity, increased competition, decreased margins, non-optimized processes and mounting compliance pressure.
Watch Now

See the Impossible: Navigating Pharma Procurement in a Complicated World

go.meetings-incentives

M&IW’s HMCC-certified buyers recently attended Pharma Forum and picked up the latest and greatest tips on sourcing healthcare meetings. In our next See the Impossible Webinar Series, learn how transparency, accountability and creative thinking can alleviate unnecessary back and forth and streamline the hotel procurement process.
Watch Now

New Drug Pricing Strategies for a Changing Global Market

questexweb

Biopharmaceutical companies are increasingly challenged to create a drug pricing strategy that both rewards value and innovation, and promotes affordability and access. During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, and provide analysis and commentary on key drug pricing issues, including:
Watch Now

Patient-Centered Measurement: How Close Are We?

Milken Institute

When it comes to medical product discovery, development, and delivery, patients need to be front and center but how close (or far away) are we from truly having a system that routinely measures what matters to patients? A panel of industry, regulatory, and patient leaders will discuss what’s next for patient-centered measurement. Panelists will define patient-centered measurement; identify novel strategies for capturing patient-centered outcomes; assess the progress in product development, regulatory approval, and delivery; and address how to advance the science of patient input in a way that fulfills the unmet needs of patients across diseases.
Watch Now

Spotlight

resources